Middle East And Africa Cardiac Monitoring Market Size

Middle East And Africa Cardiac Monitoring Market Analysis

The Middle East And Africa Cardiac Monitoring Market size is estimated at USD 1.19 billion in 2024, and is expected to reach USD 1.38 billion by 2029, growing at a CAGR of 3.22% during the forecast period (2024-2029).

• COVID-19 had a significant impact on the growth of the market initially, as there were various lockdown restrictions imposed in the region. For instance, according to the study published by PubMed in April 2021, patients infected with COVID-19 were highly prevalent with cardiovascular diseases in Saudi Arabia. The major risk factors associated with these diseases in COVID-19 patients were pneumonia and increased length of stay in the hospital. This study suggested that COVID-19 patients were at higher risk of cardiovascular diseases, which expectedly led to more adoption of cardiac monitoring devices. Thus, the pandemic affected the market significantly in the initial phase. Also, during the post-pandemic period, the increasing adoption of cardiac monitoring in the Middle East and Africa region is expected to contribute to the growth of the market.
• The market is driven by an increase in the prevalence of heart diseases, a growing aging population who are very susceptible to coronary heart diseases, and improved efficiency of devices. Countries in the Middle East and Africa have a high incidence of cardiac diseases. The rate of diagnosis of cardiovascular diseases is increasing over time due to the high incidence rate of cardiac diseases and the need to control the mortality rate through early diagnosis and treatment for cardiovascular disease with the help of cardiac monitoring devices. Hence, a rise in the incidence of cardiovascular diseases drives the market.
• Moreover, according to the United Nations Population Fund's World Population Dashboard's Statistics 2022, in the United Arab Emirates, approximately 2% of the population of the country is aged 65 years and above. In addition, as per the same source, approximately 4% of the population of the country will be aged 65 years and above in 2022. As the geriatric population is prone to suffer from various chronic diseases such as cardiovascular diseases, the anticipated increase in population is expected to fuel the demand for patient monitoring. Other factors, such as investments in R&D for innovative product development, ease of use and portability in devices, and the demand for home-based, point-of-care, and remote monitoring cardiac systems, are the major drivers for the market.
• However, the rising rate of infections due to these devices has tremendous economic implications for hospitals.